MEDI-TEK
ActiveMEDI-TEK has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €60k and a net result of €2k. Equity is growing by ~12.1% per year across the filed fiscal years. Its solvency ranks better than 67% of 1511 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).
Checked score
Score 2025
65
/ 100
Healthy
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability71▼-5
Solvency75▲+5
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
1.4%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3.5k at 30 days acceptable
Liquidity tight (current ratio 1.36 against 1.27 in 2024; short-term debt: 41.6% and cash: 13.8% of total assets), and 49.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 77
Relative position
BE, all sectors
reference
Sector 77
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
50.2%
Return on assets
1.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
8 d early
2024
42 d early
2023
23 d early
2022
7 d early
2021
39 d early
2020
16 d early
2019
40 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€60k▲ 3.4%
2024 · €58k
2018: €27k
2019: €33k
2020: €43k
2021: €40k
2022: €45k
2023: €51k
2024: €58k
2018 → 2025
Total assets
€120k▼ 7.3%
2024 · €130k
2018: €109k
2019: €142k
2020: €130k
2021: €126k
2022: €129k
2023: €126k
2024: €130k
2018 → 2025
Net result
€2k▼ 72.8%
2024 · €7k
2018: €5k
2019: €6k
2020: €9k
2021: €-3k
2022: €6k
2023: €6k
2024: €7k
2018 → 2025
Working capital
€18k▲ 41.9%
2024 · €13k
2018: €-225
2019: €12k
2020: €25k
2021: €18k
2022: €30k
2023: €9k
2024: €13k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€40k-€45k▲ 13.9%€51k▲ 12.4%€58k▲ 14.4%€60k▲ 3.4%
Operating result€-1k-€9k€7k▼ 23.7%€10k▲ 43.1%€4k▼ 57.4%
Net result€-3k-€6k€6k▲ 1.8%€7k▲ 30.1%€2k▼ 72.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 57% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €120k
Fixed assets
€52k▼ 24.8%
Current assets
€68k▲ 12.8%
Equity and liabilities €120k
Equity
€60k▲ 3.4%
Debt
€60k▼ 16.1%
The debt ratio falls from 55.0% to 49.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€23k▼
2024 · €29k
Cash flow
€21k▼
2024 · €26k
Solvency
50.2%▲
2024 · 45.0%
Current ratio
1.36▲
2024 · 1.27
Quick ratio
0.62▲
2024 · 0.44
Debt / equity
0.99▼
2024 · 1.22
ROE
3.3%▼
2024 · 12.6%
ROA
1.7%▼
2024 · 5.6%
Interest coverage
19.95▼
2024 · 20.17
Debt
€60k▼
2024 · €71k
Debt ≤ 1 year
€50k▲
2024 · €48k
Debt > 1 year
€10k▼
2024 · €24k
Income taxes
€1k▼
2024 · €2k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€130k€120k▼
Fixed assets21/28€69k€52k▼
Intangible fixed assets21€1k€1k▼
Tangible fixed assets22/27€66k€49k▼
Plant, machinery and equipment23-€2k
Furniture and vehicles24€66k€48k▼
Financial fixed assets28€2k€2k=
Current assets29/58€60k€68k▲
Stocks and contracts in progress3€40k€37k▼
Stocks30/36€40k€37k▼
Amounts receivable within one year40/41€13k€13k▲
Trade receivables40€7k€6k▼
Other amounts receivable41€6k€7k▲
Cash at bank and in hand54/58€7k€17k▲
Deferred charges and accrued income490/1€632€1k▲
Equity and liabilities
Total equity and liabilities10/49€130k€120k▼
Equity10/15€58k€60k▲
Contributions10/11€19k€19k=
Reserves13€1k€1k=
Non-distributable reserves130/1€1k€1k=
Other1319€1k€1k=
Profit (loss) carried forward14€39k€41k▲
Amounts payable17/49€71k€60k▼
Amounts payable after more than one year17€24k€10k▼
Financial debts170/4€24k€10k▼
Amounts payable within one year42/48€48k€50k▲
Current portion of amounts payable after more than one year42€14k€14k▲
Trade debts44€6k€7k▲
Suppliers440/4€6k€7k▲
Advances received on contracts in progress46€9k€9k▲
Taxes, remuneration and social security45€47€49▲
Remuneration and social security454/9€47€49▲
Other amounts payable47/48€20k€20k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€19k▲
Other operating charges640/8€3k€3k▼
Non-recurring operating charges66A€5k-
Gross operating margin9900€37k€27k▼
Operating profit (loss)9901€10k€4k▼
Financial income75/76B€2€67▲
Recurring financial income75€2€67▲
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€9k€3k▼
Income taxes67/77€2k€1k▼
Profit (loss) for the period9904€7k€2k▼
Profit (loss) for the period to be appropriated9905€7k€2k▼
Appropriation of the result
Profit (loss) to be appropriated9906€39k€41k▲
Profit (loss) brought forward from the previous period14P€31k€39k▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
19-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
08-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
24-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Back to profitnet €6k
Net result €6k after one loss-making year.
22-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet €-3k ▼129%
Net result drops to €-3k, the lowest in the series; recovery starts the following year.
15-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Highest result since 2018net €9k ▲52.4%
Operating result €14k, net result €9k, both a record.
09-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 40 days late
2019
01-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
18-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jette · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gustave Gilsonstraat 1301090 JetteGround area
453 m²
Building footprint
248 m²
Volume, LiDAR
2,980 m³
2 parcels, Brussels · tallest building 17.8 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
MEDI-TEK
since 20172.261.828.281
2 parcels
Brussels
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21010B0162/00M002 | Brussels | 289 m² | 1 · 157 m² | 17.8 m · 5 fl. |
| 21010B0149/00A008 | Brussels | 164 m² | 1 · 91 m² | 13.3 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PORTYVIT
BE 0891.803.152
Braine-l'Alleud · Eq €64k
CARE&BUILD INVEST
BE 0811.319.579
Zedelgem · Eq €57k
MEDIKFIT
BE 0662.410.426
Schoten · Eq €65k
VEGAMEE
BE 0883.318.424
Knokke-Heist · Eq €55k
ZILVER
BE 0754.865.579
Oostende · Eq €67k
Of 142 companies in sector 77225 we hold annual accounts for 79. 57 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-02-2017
Fiscal year end31-12
Activities, NACEBEL
77225Rental and leasing activities
46150Agents in the wholesale of furniture, household goods and hardware
46460Wholesale of pharmaceutical and medical goods
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 9 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.